Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $16.8600 (8.25%) ($16.8600 - $16.8600) on Thu. Dec. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.63% (three month average) | RSI | 19 | Latest Price | $16.8600(8.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -8% a day on average for past five trading days. | Weekly Trend | TGTX declines -19.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(71%) ARKG(66%) IBB(64%) ARKK(62%) IWO(61%) | Factors Impacting TGTX price | TGTX will decline at least -2.815% in a week (0% probabilities). VIXM(-49%) VXX(-41%) UUP(-19%) UNG(-6%) TLT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.815% (StdDev 5.63%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-16.83(-199.82%) | Resistance Level | $26.44 | 5 Day Moving Average | $19(-11.26%) | 10 Day Moving Average | $21.58(-21.87%) | 20 Day Moving Average | $26.44(-36.23%) | To recent high | -52.6% | To recent low | 11.1% | Market Cap | $2.135b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |